Harrow Health Ownership
| HROW Stock | USD 10.27 0.05 0.48% |
Shares in Circulation | First Issued 2006-06-30 | Previous Quarter 34.3 M | Current Value 35.4 M | Avarage Shares Outstanding 13.1 M | Quarterly Volatility 11.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Harrow |
Harrow Stock Ownership Analysis
About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.75. Harrow Health had not issued any dividends in recent years. The entity had 1:5 split on the 8th of February 2013. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 182 people. To learn more about Harrow Health call Mark Baum at 615 733 4730 or check out https://www.harrow.com.Besides selling stocks to institutional investors, Harrow Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Harrow Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Harrow Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Harrow Health Quarterly Liabilities And Stockholders Equity |
|
Harrow Health Insider Trades History
About 15.0% of Harrow Health are currently held by insiders. Unlike Harrow Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Harrow Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Harrow Health's insider trades
Harrow Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Harrow Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Harrow Health backward and forwards among themselves. Harrow Health's institutional investor refers to the entity that pools money to purchase Harrow Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Stifel Financial Corp | 2023-12-31 | 432 K | Citadel Advisors Llc | 2023-09-30 | 330.9 K | Northern Trust Corp | 2023-12-31 | 316.8 K | Wasatch Advisors Lp | 2023-12-31 | 302.5 K | Royce & Associates, Lp | 2023-12-31 | 294.9 K | Franklin Resources Inc | 2023-12-31 | 294.2 K | Rice Hall James & Associates, Llc | 2023-12-31 | 231.5 K | Nuveen Asset Management, Llc | 2023-12-31 | 221.8 K | Westside Investment Management, Inc. | 2023-12-31 | 212.3 K | Opaleye Management Inc | 2023-12-31 | 3.8 M | Private Capital Management, Llc | 2023-12-31 | 2.8 M |
Harrow Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Harrow Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opaleye Management Inc. 2 days ago Acquisition by Opaleye Management Inc. of 11715 shares of Harrow Health at 10.29 subject to Rule 16b-3 | ||
Mark Baum over a month ago Acquisition by Mark Baum of 25000 shares of Harrow Health at 13. subject to Rule 16b-3 | ||
John Saharek over a month ago Disposition of 5000 shares by John Saharek of Harrow Health at 8.75 subject to Rule 16b-3 | ||
Opaleye Management Inc over three months ago Purchase by Opaleye Management Inc of 25000 shares of Harrow Health | ||
John Saharek over three months ago Exercise or conversion by John Saharek of 20000 shares of Harrow Health subject to Rule 16b-3 | ||
Opaleye Management Inc over six months ago Purchase by Opaleye Management Inc of 14017 shares of Harrow Health | ||
Opaleye Management Inc over six months ago Purchase by Opaleye Management Inc of 415000 shares of Harrow Health | ||
John Saharek over a year ago Acquisition by John Saharek of 277200 shares of Harrow Health subject to Rule 16b-3 |
Harrow Health Corporate Filings
F4 | 19th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 21st of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 19th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 13th of February 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Harrow Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Harrow Health's short interest history, or implied volatility extrapolated from Harrow Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.75) | Revenue Per Share 3.992 | Quarterly Revenue Growth 0.788 | Return On Assets 0.0022 |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.